INTRODUCTION
Rotavirus is the major aetiological agent of severe gastroenteritis in infants and young children. There are an estimated 400 000-800 000 fatal rotavirus cases each year, mostly in developing countries. In addition, despite improvements in living conditions and sanitation in developed countries, the annual incidence of rotavirus infections remains high and costs of treatment are significant. This magnitude of mortality and economic burden justify the need for introduction of effective control measures. As traditional public health interventions are inefficient in the control of rotavirus infections, the most promising alternative may be a mass vaccination programme (Kapikian & Chanock, 1996; Bresee et al., 1999; Glass et al., 1999) .
Rotaviruses, which are members of the family Reoviridae, possess a genome of 11 dsRNA segments that are enclosed in a triple-layered capsid. Rotaviruses are classified into sero-groups, designated A to G. Of these, group A rotaviruses are the major enteropathogenic viruses in infancy (Kapikian & Chanock, 1996) . Based on antigenic differences of the surface antigens, VP7 and VP4, group A rotaviruses can be further classified into G and P serotypes, respectively. Nucleic acidbased genotyping methods (e.g. sequencing, RT-PCR or probe hybridization) to identify the genetically distinct genes that specify individual G and P serotypes have also been developed (Flores et al., 1989; Gouvea et al., 1990; Larralde & Flores, 1990; Gentsch et al., 1992) .
In epidemiological surveys, both antigenic typing with serotype-specific mAbs and genotyping techniques are used frequently for determination of G serotype specificity. In contrast, as mAbs to common P serotypes are cross-reactive and neutralization assays are cumbersome and require tissue culture-adapted strains, genotyping methods are used widely for P type identification.
To date, 10 G serotypes (G1-G6, G8-G10 and G12) and 11 P genotypes (P[1], P[3]-P[6], P[8]-P[11], P [14] and P [19] ) are known to cause infection in humans (Nakagomi et al., 1994; Hoshino & Kapikian, 2000; Jagannath et al., 2000; Okada et al., 2000) . Although the theoretical number of P-G antigen combinations that could be generated from individual types is very large, only a few of these have epidemiological significance. Historically, four major strains (P[8],G1; P[4],G2; P[8],G3; and P[8],G4) have been linked to about 90-95 % of hospital-associated infections (Gentsch et al., 1996) . The G serotype specificities of these four strains are the targets of vaccine development, as exemplified by the first licensed rotavirus vaccine, called rhesus rotavirus (RRV) tetravalent vaccine (RRV-TV) or RotaShield, the trade name assigned by its US manufacturer. This vaccine contained the RRV parent strain, which shares VP7 specificity with that of human G3 strains, and three rhesus-human mono-reassortant strains, with the VP7 genes of human rotavirus serotypes G1, G2 and G4, respectively, and the remaining 10 genes of the RRV parent (Midthun et al., 1985) . RotaShield was approved in 1998 by the Food and Drug Administration for routine administration in US children. In 1999, however, due to a rare association between vaccine use and severe bowel obstruction in vaccinees, the vaccine was withdrawn from the US market (CDC, 1999a, b) . Despite these serious adverse effects of vaccination with RotaShield, further efforts at finding safe and effective vaccines are under way (Clark et al., 1996; Bernstein et al., 1998; Clements-Mann et al., 2001) .
In anticipation of possible national immunization programmes against rotavirus, intensified surveillance has begun worldwide to assess rotavirus disease burden in countries that are considering use of vaccines and to determine the relative importance of common and rare serotypes in individual countries. These studies will help to determine the need for rotavirus vaccines in countries worldwide and in the formulation of vaccines that contain the most common serotype antigens that are capable of eliciting adequate typespecific or heterotypic immunity.
Strain prevalence surveys, supported by improved detection and typing methods, have led to increased identification of serotypes that were previously considered to be rare or that had never been detected before. Some of these may only have local significance (e.g. G5 in parts of Brazil and G8 in Malawi; Bok et al., 2001b; Cunliffe et al., 2001b) , but at least one serotype, G9, was demonstrated to have dispersed worldwide (Ramachandran et al., 1996; Unicomb et al., 1999; Griffin et al., 2000; Iturriza-Gó mara et al., 2000; Palombo et al., 2000; Araú jo et al., 2001; Bok et al., 2001a; Cunliffe et al., 2001a; Bányai et al., 2004) .
Serotype G9, as the sixth recognized human VP7 specificity, was first identified during 1983 in the USA and from 1985 to 1989 in Japan, India, Yugoslavia and Thailand (Clark et al., 1987; Nakagomi et al., 1988 Nakagomi et al., , 1990 Urasawa et al., 1992; Zizdic et al., 1992; Das et al., 1993) . Representative US and Japanese G9 strains carried P[8] VP4 specificity, possessed a 'long' electropherotype (E-type; also referred to as genome pattern or RNA profile) and, as determined by wholegenome RNA-RNA hybridization, exhibited close genomic relatedness to strain Wa (P1A[8],G1), the prototype of the most common human rotaviruses, designated the Wa genogroup (Nakagomi et al., 1990) . The Indian G9 strains, which were only identified in neonates who excreted rotavirus without symptoms of diarrhoea, had P[11] or P[6] VP4 specificity, 'long' E-types and were also members of the Wa genogroup Laird et al., 2003) . The P[11] VP4 gene is related closely to the cognate gene of bovine strain B223, suggesting that these strains were derived by reassortment with bovine rotaviruses . Two G9 strains that were detected in Thailand had P [19] genotype specificity and genomic relatedness with porcine rotaviruses (Urasawa et al., 1992; Okada et al., 2000) . Although highly diverse, the small number of reports of G9 detection before 1990 suggested that these strains were a relatively uncommon cause of gastroenteritis.
Beginning in the mid-1990s, G9 strains apparently emerged globally (Ramachandran et al., 1996; Unicomb et al., 1999; Griffin et al., 2000; Widdowson et al., 2000; Cunliffe et al., 2001a) . The G9 rotaviruses identified more recently exhibited a great variety of genomic constellations, formed predominantly by reassortment of VP4 and VP7 genes into both 'long' and 'short' E-type strains. For example, P[4],G9 'short' E-type strains were identified in Thailand; P[4],G9 'long' E-type strains were found in Brazil; P[6],G9 'short' Etype strains were detected in the USA, India and Bangladesh; P[6],G9 'long' E-type strains were detected in India, Bangladesh and Kenya; and P[8] ,G9 'long' E-type strains circulated in the USA, Bangladesh, Libya, Cuba, Kenya, India and Japan (Unicomb et al., 1999; Griffin et al., 2000; Oka et al., 2000; Ramachandran et al., 2000; Araú jo et al., 2001; Cunliffe et al., 2001a; Jain et al., 2001; Zhou et al., 2001) .
During a 1997-1998 longitudinal study in Hungary, P[8],G9 'long' E-type strains were detected for the first time in our country. Subsequently, during 1999 Subsequently, during -2001 ,G9 rotaviruses were detected at an increased prevalence and were the second most common strain detected during this period (Bányai et al., 2004) . In this report, we describe the findings of RNA profile analysis, which we used to study geographical and temporal changes within G9 strains that circulated between 1998 and 2001 in Hungary. Moreover, sequence and phylogenetic analyses were performed for the outer capsid genes (VP7 and VP4) to investigate the genetic relationship among Hungarian strains and G9 strains identified in other countries, in order to help to understand the epidemiology and evolution of these emerging rotaviruses.
METHODS
Specimens. Serotype G9 rotaviruses characterized in this report were identified during a surveillance study by using mAb-based enzyme immunoassay serotyping (Coulson et al., 1987; Taniguchi et al., 1987) and RT-PCR (Gentsch et al., 1992; Das et al., 1994) genotyping (Bányai et al., 2004) . Of 219 specimens that were found to be positive for serotype G9 rotaviruses between 1998 and 2001 (Table 1) , nine strains were selected for sequence analysis on the basis of differences in RNA profiles and year and place of identification. Of these, eight samples were collected in Budapest, Hungary [Hun9 (1997 RNA extraction. Rotavirus dsRNA was extracted from diluted faecal specimens by the guanidine thiocyanate/glass milk method, as described previously (Gentsch et al., 1992) .
RNA profile analysis. We analysed the viral genome by PAGE and silver staining (Laemmli, 1970; Dolan et al., 1985) . We used the tissue culture-adapted strain WI61 (P[8],G9) as a control (Clark et al., 1987) .
Nucleotide sequencing. The outer capsid genes VP7 and VP8* (a fragment of the VP4 gene) were reverse-transcribed and the resulting cDNA was amplified by using the consensus primers 9con1 and 9con2, and con3 and con2, respectively (Gentsch et al., 1992; Das et al., 1994) . Amplicons were run in a low-melting-point agarose gel, subsequently excised and then extracted with a QIAquick Gel Extraction kit (Qiagen). Nucleic acid sequencing was performed with a BigDye Terminator Cycle Sequencing kit v2.0 (Applied Biosystems) by using the individual primers that were used to generate the RT-PCR products. Where needed, primers homologous to internal regions of the RT-PCR products were utilized to complete the sequence (not shown). Dyelabelled products were extracted by sodium acetate/ethanol precipitation. The pellet was resuspended in formamide and then run on an automated sequencer (ABI Prism 310; Applied Biosystems).
Sequence and phylogenetic analysis. Nucleotide sequences were aligned with those available in GenBank/EMBL/DDBJ by using the program DAMBE (Xia & Xie, 2001 ) and edited with the program GeneDoc v2.3 (Nicholas et al., 1997) . The phylogenetic relationship between strains was estimated by maximum-likelihood and distance matrix analysis followed by the neighbour-joining tree reconstruction algorithm. Robustness of the trees was assessed by bootstrap analysis. The computer simulation was performed with the PHYLIP 3.5 and MEGA2 software packages (Felsenstein, 1989; Kumar et al., 2001) .
GenBank accession numbers. Partial sequences of the VP7 and VP4 genes were deposited in GenBank under the following accession numbers: VP7, AJ605303-AJ605311; VP4, AJ605312-AJ605320. G9 VP7 and P[8] VP4 sequences that are available for public use were downloaded from GenBank/EMBL/DDBJ after a sequence similarity search was done with the BLAST search algorithm (Altschul et al., 1997) .
RESULTS

RNA profile analysis of Hungarian G9 strains
When Hungarian P[8],G9 strains were analysed by electropherotyping, four distinct RNA profiles were identified. When a strain representative of each RNA profile was compared to the prototype US P1A[8],G9 strain, WI61, each Hungarian isolate had several segment migration differences from the prototype (Fig. 1) . For the purpose of comparing profiles among Hungarian G9 rotaviruses, the profile of strain Hun9 was designated as profile A (E-type A), as it was the first P[8],G9 strain to be identified in Hungary. When we compared E-type A with E-type B, migration differences for gene segments 2, 3, 4, 5, 6 and 10 were seen. In E-type C, gene Characterization of P[8],G9 rotaviruses segment 7 migrated more slowly than its cognate gene segment in E-type A. In addition, we found two variants within E-type C, one of which had an identical mobility of gene segment 10, to E-type A (data not shown), whereas the other had a gene segment 10 that migrated slightly more slowly than gene 10 of E-type A (Fig. 1) . As it was not always possible to distinguish the two E-type C variants, both were classified into the same major E-type. In the E-type D pattern, only a single major difference was evident: gene segment 4 migrated more slowly than its cognate gene in E-type A.
Analysis of the seasonal distribution of the four E-types demonstrated that E-type A was the only strain found in 1997-1998 and 1998-1999 . It was the predominant G9 strain in the following season (Table 1) . During the 2000-2001 rotavirus season, strains with E-type C were detected for the first time and were predominant over strains with other E-types. The two unique strains that were designated E-types B and D, respectively, were detected only in 1999-2000 and 2000-2001 . Only strains with E-type A profiles circulated in both Hungarian surveillance areas, whereas E-type B, C and D strains were identified only among the Budapest samples.
Sequencing and phylogenetic analysis of VP7 and VP8* genes
To assess the evolutionary relationships among Hungarian G9 strains and compare them to G9 strains that were isolated in different countries, phylogenetic analysis was performed for the outer capsid proteins VP7 and VP4.
Analysis of nucleotide sequences revealed a close relationship among the G9 VP7 genes of Hungarian strains (.98 % sequence similarity; data not shown) and a similar extent of sequence similarity to most G9 strains that have been identified recently in European, American, African and Asian countries (.96 %). A unique strain, CIT-254RV (identified in Ireland), was related more closely to members of the globally emerged G9 lineage, despite having relatively low sequence similarity (95 . 2-93 . 0 %) to those strains, including the Hungarian G9 strains (Fig. 2) .
All Hungarian G9 strains and most recently detected strains from other countries formed a closely related cluster that was distinct from the original P[8],G9 strains that were isolated during the 1980s in the USA (WI61) and Japan (F45, AU32) (Fig. 2) (Fig. 2) .
Phylogenetic analysis of VP8* sequences indicated that Hungarian P[8],G9 strains clustered in two separate branches (Fig. 3) . Seven of nine study strains (i.e. E-type A strains Hun9, BP850/00, BP857/00, BC4572/00 and BP641/ 01 and E-type C strains BP626/01 and BP1744/01) clustered together and shared .98 % sequence similarity with each other (nt 33-564; data not shown). Two of those seven strains for which a longer nucleotide sequence was determined (Hun9 and BP857/00; nt 33-850) shared highest similarity (.98 %) with other G9 strains identified recently in the UK and India (e.g. 466/97 and 02-RV35, respectively) and with G1 isolates identified in Taiwan (strain TF101) and Malawi (e.g. OP351 and OP601). All of these strains and others, including reference strain P, a P1A[8],G3 isolate from the USA (Wyatt et al., 1983) , formed a genetic cluster (designated P-like) that was distinct from the three earlier described VP8* lineages (i.e. Wa-like or lineage I, F45-like or lineage II, and MW670-like or lineage III) (Maunula & von Bonsdorff, 1998; Gouvea et al., 1999) . However, bootstrap analysis demonstrated that P-like strains, including Hun9 and BP857/00, are actually genetically divergent members of lineage II (F45-like; Fig. 3 ). This conclusion is supported by the findings of both non-silent (nucleotide positions 494, 576 and 593; corresponding amino acid positions are 162, 189 and 195, respectively) and silent nucleotide substitutions (nucleotide positions 87, 105, 126, 141, 171, 297, 588, 609, 672 and 676) that are highly conserved among members of these two lineage II genetic clusters (Table 2 ). In contrast, Etype B (BP785/00) and D (BP1829/01) strains were distinct from these seven Hungarian G9 strains (,91 % similarity; nt Representative strains with the indicated RNA profiles were as follows: A, Hun9, BP850/00, BP857/00, BC4572/00 and BP641/01; B, BP785/00; C, BP626/01 and BP1744/01; D, BP1829/01. Triangles in the line drawings of E-types B, C and D (to the right of the gel presentation) indicate major differences in the genome pattern found, compared to pattern A (designated as the prototype Hungarian E-type associated with G9 VP7 specificity). 33-564). They shared 96 . 3 % nucleotide sequence similarity with each other (nt 33-850) and were related more closely to reference strain Wa (lineage I) than to strains in other clusters (e.g. P-like, F45-like or MW670-like strains).
DISCUSSION
From its first detection in 1983 until the early 1990s, serotype G9 was rarely identified globally as a cause of diarrhoea, although it was known as a common cause of asymptomatic infections in Indian neonates (Clark et al., 1987; Nakagomi et al., 1990; Urasawa et al., 1992; Zizdic et al., 1992; Das et al., 1993) . Beginning in the mid-1990s, there was a remarkable increase in the detection of G9 strains as a cause of gastroenteritis and over the last 7 years or so, G9 rotaviruses have emerged as one of the most epidemiologically important strains worldwide in both developed and developing countries (Ramachandran et al., 1996; Griffin et al., 2000; Iturriza-Gó mara et al., 2000; Palombo et al., 2000; Widdowson et al., 2000; Araú jo et al., 2001; Bányai et al., 2004) .
To determine whether emergence of G9 rotaviruses may have been associated with the spread of a single strain or with several distinct strains, studies on the sequence relatedness of G9 VP7 genes of strains from different geographical locations have been conducted. Sequence data to date suggest that the vast majority of currently circulating G9 strains from different locations and different years belong to one closely related phylogenetic lineage of the G9 VP7 gene. This is consistent with the introduction of a single strain, followed by spread and genetic variation in that lineage. These strains are phylogenetically distinct from those reported in the 1980s and also from a few recent isolates, suggesting that a recent common progenitor donated this new G9 VP7 gene.
Available sequence and epidemiological data are insufficient to ascertain whether modern serotype G9 human rotavirus strains represent the progeny of a single ancient strain or multiple, independent introductions. With one known exception (strain CIT-254RV; O'Halloran et al., 2002) , the serotype G9 VP7 gene is uniformly 1061 bp in length, i.e. 1 nt shorter than most other mammalian rotavirus VP7 genes (Estes & Cohen, 1989) . It has been hypothesized that the G9 VP7 gene was generated by a single nucleotide deletion within or at the end of the termination codon of G9 strains Das et al., 1993) . The former hypothesis suggested that the deletion within the termination codon resulted in a new stop codon for G9 strains, UGA, instead of UAG as found in most other human rotavirus G serotypes (Estes & Cohen, 1989; Das et al., 1993) . Assuming that this deletion and shift in stop codon usage resulted from a single, ancient molecular event, this finding suggests the early existence of a common ancestor for all or virtually all human rotavirus G9 lineages, including the first isolates from the USA, Japan and India. This observation raises interesting questions about the evolution of the modern lineage from these early lineages and whether these changes occurred in the same host species or accumulated during the course of multiple host switches.
The identification of several modern G9 rotavirus lineages that are related to the earliest G9 isolates from the 1980s suggests that most of these strains may represent phylogen- 
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etically distant progeny of those early strains, which may have continued to circulate in humans without detection. In addition to the modern south-east Asian G9 isolates (e.g. 684VN; Nguyen et al., 2001 ), a number of far-east Asian strains detected in Japan (Zhou et al., 2003) and China (Li et al., 1997) in the late 1990s, or even the predominant, globally distributed modern lineage that is related relatively closely to Mc323-like strains, may support this hypothesis, based on distance and phylogenetic analysis. This hypothesis underscores the importance of continuous and strong genetic drift that has resulted in the segregation of all currently recognized lineages. However, the lack of substantial sequence divergence observed within the predominant modern G9 lineage over a 10 year period contradicts this hypothesis. Thus, the lack of divergence among most modern G9 VP7 genes, together with the observation that substantial differences exist in the genomic constellation of several modern isolates (Laird et al., 2003) , suggest that at least some of these lineages may represent independent introductions into the human G9 VP7 gene pool from an unknown source, which could include an animal reservoir.
In fact, early reports demonstrating that some Asian G9 rotavirus isolates were porcine-human or bovine-human reassortants (Urasawa et al., 1992 suggested that genetic interaction between animal and human rotavirus strains may have occurred in the same host. Furthermore, detection of G9 strains in diarrhoeic pigs and the presence of G9-specific antibodies in lambs provide some indirect support for the hypothesis that human G9 rotaviruses could have originated in an animal species (Muñoz et al., 1995; Santos et al., 1999) . Additional studies on the genetic relationship between G9 VP7 genes of rotaviruses from animals and humans may shed light on this hypothesis.
Our recent longitudinal, epidemiological survey indicated that serotype G9 rotaviruses were introduced to Hungary more recently, perhaps in the 1997-1998 season (Bányai et al., 2004) . In the present study, we have demonstrated the presence of the newly recognized, globally distributed G9 lineage in our country. By using genome-pattern analysis, we have identified four different strains circulating in Hungary over the past few years. Based on previous findings that demonstrated that substantial sequence differences may exist among cognate genome segments of electropherotypically distinct strains (Maunula & von Bonsdorff, 2002) , as did a number of P[8],G9 strains that were identified as being epidemiologically important in India (M. Iturriza-Gó mara, personal communication), the UK (Iturriza-Gó mara et al., 2001), Italy (Martella et al., 2003) and Hungary; however, these latter strains clustered in the same branch within lineage II, distinct from that represented by strain F45. Lineage III P[8] genotype was found in association with serotype G9 only in one study (Iturriza-Gó mara et al., 2001) . Further studies may elucidate whether the hypothesis that certain lineages are not favoured holds true.
From public health and economic viewpoints, a mass immunization programme against group A rotaviruses is expected to be highly beneficial for both developing and developed countries . To date, about a dozen different rotavirus vaccine candidates have been or are currently being tested. Many are multivalent vaccines that are composed of animal-human reassortant strains that contain the common human G serotype specificities G1-G4 and, in one case, the most common P serotype specificity, P1A[8] (Midthun et al., 1985; Clements-Mann et al., 2001) . All of these vaccines were developed based in part on the percep-tions that animal strains are in general naturally attenuated for humans and that serotype-specific immunity is important to prevent severe (re-)infections. RRV-TV (RotaShield) met these criteria but, due to an association with intussusception after its US introduction, it was withdrawn, leaving several questions unanswered. One important issue that remained to be studied was the extent of cross-protection raised by multivalent vaccines against serotypes that were not present in the vaccine. Thus, the emergence of strains previously considered uncommon (e.g. serotype G9) may have serious implications for future vaccination programmes.
In some early reports, infections with the novel G9 strains were associated with unusual epidemiological and clinical features. British investigators (Iturriza-Gó mara et al., 2000) found that recently emerged G9 strains caused symptomatic infections in children over 5 years of age, where pre-existing immunity was expected to provide sufficient heterotypic protection against common and, perhaps, rare serotypes. Another study reported that G9 strains caused disease in newborns, suggesting that acquired maternal antibodies did not neutralize these strains efficiently (Widdowson et al., 2000) . Both studies suggested that G9 rotaviruses escaped the pre-existing immunity evoked by other strains, possibly because these populations were immunologically naive to G9 specificity.
These findings emphasize the importance of serotypespecific immunity and support the hypothesis that an effective vaccine should represent all specificities that occur locally. Thus, if serotype G9 rotaviruses continue to be a common cause of diarrhoea in children, despite the rise of population immunity to these strains, it might be necessary to add G9 VP7 specificity to future multivalent vaccine candidates. Therefore, it will be important to monitor the ability of vaccines that are currently undergoing trials to provide heterotypic protection against G9 strains.
